Navigation Links
Life Technologies Expands Range of Stem Cell Reprogramming Solutions
Date:6/17/2013

CARLSBAD, Calif., June 17, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the launch of Epi5™ Episomal iPSC Reprogramming Vectors, the world's first product to be fully commercialized based on technology that won its developers a Nobel Prize in 2012 for the ability to easily reprogram adult human cells into an early embryonic state.

Scientists use induced pluripotent stem cell (iPSC) technology to create iPSCs from patient-derived adult somatic cells. The iPSCs can then be differentiated into many cell types, such as neurons and hepatocytes, to be studied in the lab. The ease-of-use and reprogramming efficiency of Epi5™ Episomal iPSC Reprogramming Vectors helps accelerate the process for applications in basic research and pre-clinical studies.

"You can give rise to iPSCs at a high efficiency rate by using the Epi5™ Episomal iPSC Reprogramming Kit," said Dr. Keisuke Okita, Lecturer, Center for iPS Cell Research and Application, Kyoto University, who helped developed the Nobel Prize-winning technology with Dr. Shinya Yamanaka. "We are delighted to see that Life Technologies is taking the lead to make it available and we hope that many researchers will use it to advance research in areas such as pathology, drug discovery and stem cell biology."

While other reprogramming vectors have been developed in Dr. Yamanaka's lab, none has ever been commercially available. Epi5™ Episomal iPSC Reprogramming Vectors is the result of a global, non-exclusive license agreement Life Technologies signed last year with iPS Academia Japan for its iPSC patent portfolio. The license expands Life's
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Drug Delivery in Cancer - Technologies, Markets and Companies 2013
2. Life Technologies Acquires LSK, Leading Instruments Distributor in Korea
3. Micell Technologies Receives CE Mark Approval for MiStent SES
4. Development of New Technologies Spurs Molecular Diagnostic Test Volumes in Asia-Pacific, Finds Frost & Sullivan
5. Frost & Sullivan Market Share Leadership Award Highlights Acuo Technologies Accomplishments in Enterprise Imaging Informatics
6. Finalists Announced for Israel Brain Technologies Million Dollar Global B.R.A.I.N. Prize
7. Breathe Technologies Sleep System Receives FDA Clearance
8. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
9. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
10. Global Markets and Technologies for Optical Coherence Tomography (OCT)
11. Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... VEGAS , July 30, 2014  DigiPath, Inc. ... that is expanding into the cannabis testing and education ... in its business and affairs not previously disclosed or, ... the recent unusual market action. "We have ... over the last three trading days," said Steve ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... , , SAN DIEGO , Jan. 15 ... entry of a settlement agreement which will resolve the consolidated securities ... Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay ... the company has agreed to issue to the plaintiffs, class a ...
... , , , , , , ... Jan. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China ... a,leading fully integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has relocated its headquarters to its new buildings,in ...
Cached Medicine Technology:Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 2Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 3Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 4China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 2China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 3
(Date:7/30/2014)... Aquarium Research Institute (MBARI) have observed a deep-sea octopus ... than any other known animal. Throughout this time, the ... predators. This amazing feat represents an evolutionary balancing act ... plenty of time to develop within their eggs, and ... or no food. , Every few months for the ...
(Date:7/30/2014)... -- For patients with asthma, just believing an odor ... for at least 24 hours, a new study indicates. ... what you think you smell," study author Cristina Jaen, ... said in a Monell news release. "Asthmatics ... expect that an odor is harmful, our bodies react ...
(Date:7/30/2014)... who were breastfed for three months or more ... chronic inflammation associated with cardiovascular and metabolic diseases, ... Washington University in St. Louis. , "This study ... for children,s health decades later," said Molly W. ... and a co-author of the study with Thomas ...
(Date:7/30/2014)... ‚ÄúToday, we have said ¡Basta! (enough) to the ... to our children and our families. The SWEET Act ... to put the health of people first and make ... President and CEO of the National Alliance for Hispanic ... (SWEET) Act by Congresswoman Rosa L. DeLauro. , The ...
(Date:7/30/2014)... With the recent May 21st opening of the ... Museum Workshop in the Meatpacking District has been encountering some ... Carole Barnes, "We have had to re-write the description of ... who sell us so tourists don't confuse the two 9/11 ... we do and what the new Museum does in terms ...
Breaking Medicine News(10 mins):Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Birthweight and breastfeeding have implications for children's health decades later 2Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 3Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 4Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 5
... the Division of Allergy and Immunology at Cincinnati ... extend funding of his long-standing investigation into "Regulation ... award from the National Institute of Allergy and ... of research accomplishment." Eosinophilic disorders occur ...
... HealthDay Reporter , THURSDAY, July 22 (HealthDay News) ... a result of taking statins don,t seem to benefit from ... The conventional wisdom has been that to reduce the ... LDL, or "bad," cholesterol and increase your HDL, or ...
... specific brain regions in female patients with irritable bowel syndrome ... abdomen, along with diarrhea, constipation or both. ... the study appears in the July issue of the journal ... IBS is associated with both decreases and increases in grey ...
... include certain must-have vitamins in their diets to stave off ... Alberta. , A study of 43 children and teens ... disease showed that they also tended to have low bone ... and minerals. That means they should be getting more of ...
... study into the causes of deaths of workers at ... rates from all causes and cancer in general when ... known by occupational health researchers as the "healthy worker ... such as leukemia or multiple myeloma were slightly above ...
... total joint replacement registry based on carefully designed and ... cost-effectiveness and research, according to a paper published in ... and Related Research , a journal of the Association ... Total Joint Replacement Registry the nation,s largest such registry ...
Cached Medicine News:Health News:Doctor at Cincinnati Children's receives prestigious NIH MERIT Award 2Health News:Some on Statins May Not Need Boost in 'Good' Cholesterol 2Health News:Some on Statins May Not Need Boost in 'Good' Cholesterol 3Health News:Study finds structural brain alterations in patients with irritable bowel syndrome 2Health News:Study finds structural brain alterations in patients with irritable bowel syndrome 3Health News:Study describes health effects of occupational exposures in Paducah Gaseous Diffusion Plant workers 2Health News:Kaiser Permanente demonstrates success of large-scale total joint replacement registry 2
... High Productivity, improved safety and lower cost per ... solution to sample prep bottlenecks in the busy ... amazingly compact and quiet centrifuge spins standard 5 ... yet it produces quality serum or plasma equal ...
The StatSpin Express 3 provides faster turnaround time and greater productivity for your laboratory....
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
Used for stenting the urethra during hypospadias or epispadias repair and to promote postoperative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: